Showing results (111-120 of 676) with videos related to

Sort By:
Pageof 68
Expert Review of Molecular Diagnostics|November 1, 2016
Validation of a multiplexing technique to determine the intrathecal, polyspecific antiviral immune response in multiple sclerosisAndré Huss, Mathias Buttmann, Isabel Brecht, et al.
Progress in Neurobiology|June 19, 2010
Animal models of multiple sclerosis--potentials and limitationsEilhard Mix, Hans Meyer-Rienecker, Hans-Peter Hartung, et al.
BMC Neuroscience|August 8, 2009
Niche-dependent development of functional neuronal networks from embryonic stem cell-derived neural populationsSebastian Illes, Stephan Theiss, Hans-Peter Hartung, et al.
Muscle & Nerve|April 21, 2020
Management challenges for chronic dysimmune neuropathies during the COVID-19 pandemicYusuf A Rajabally, H Stephan Goedee, Shahram Attarian, et al.
Current Opinion in Neurology|May 14, 2021
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosisHans-Peter Hartung, Sven G Meuth, Deborah M Miller, et al.
Journal of Neurology|November 19, 2009
Development of oral cladribine for the treatment of multiple sclerosisHans-Peter Hartung, Orhan Aktas, Bernd Kieseier, et al.
Neuropharmacology|October 22, 2008
Neural precursor cells as a novel target for interferon-betaJennifer Wellen, Janine Walter, Parastoo Jangouk, et al.
The Lancet. Neurology|June 21, 2005
Immune response to immunotherapy: the role of neutralising antibodies to interferon beta in the treatment of multiple sclerosisBernhard Hemmer, Olaf Stüve, Bernd Kieseier, et al.
Brain and Behavior|July 22, 2021
Type O blood group associates with higher anti-JC polyomavirus antibody levelsPia Frenken, Hans-Peter Hartung, Tomas Olsson, et al.
Biochimica Et Biophysica Acta|February 10, 2015
Redox-regulated fate of neural stem progenitor cellsTim Prozorovski, Reiner Schneider, Carsten Berndt, et al.
Pageof 68